Orgenesis Inc. (ORGS)
Orgenesis Statistics
Share Statistics
Orgenesis has 5.17M shares outstanding. The number of shares has increased by -84.86% in one year.
| Shares Outstanding | 5.17M |
| Shares Change (YoY) | -84.86% |
| Shares Change (QoQ) | 8.4% |
| Owned by Institutions (%) | 4.68% |
| Shares Floating | 3.48M |
| Failed to Deliver (FTD) Shares | 182 |
| FTD / Avg. Volume | 1.4% |
Short Selling Information
The latest short interest is 56.25K, so 1.18% of the outstanding shares have been sold short.
| Short Interest | 56.25K |
| Short % of Shares Out | 1.18% |
| Short % of Float | 1.34% |
| Short Ratio (days to cover) | 2.39 |
Valuation Ratios
The PE ratio is -2.62 and the forward PE ratio is 2.21. Orgenesis's PEG ratio is -0.01.
| PE Ratio | -2.62 |
| Forward PE | 2.21 |
| PS Ratio | 273.66 |
| Forward PS | 0.2 |
| PB Ratio | -6.91 |
| P/FCF Ratio | -8.57 |
| PEG Ratio | -0.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Orgenesis.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.25, with a Debt / Equity ratio of -1.08.
| Current Ratio | 0.25 |
| Quick Ratio | 0.25 |
| Debt / Equity | -1.08 |
| Debt / EBITDA | -0.37 |
| Debt / FCF | -1.34 |
| Interest Coverage | -24.75 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $3.63K |
| Profits Per Employee | $-379.18K |
| Employee Count | 146 |
| Asset Turnover | 0.04 |
| Inventory Turnover | 183.97 |
Taxes
| Income Tax | 473K |
| Effective Tax Rate | -0.73% |
Stock Price Statistics
The stock price has increased by -55.17% in the last 52 weeks. The beta is 0.89, so Orgenesis's price volatility has been higher than the market average.
| Beta | 0.89 |
| 52-Week Price Change | -55.17% |
| 50-Day Moving Average | 2.5 |
| 200-Day Moving Average | 3.71 |
| Relative Strength Index (RSI) | 46.73 |
| Average Volume (20 Days) | 12.96K |
Income Statement
In the last 12 months, Orgenesis had revenue of 530K and earned -55.36M in profits. Earnings per share was -1.91.
| Revenue | 530K |
| Gross Profit | -5.72M |
| Operating Income | -53.64M |
| Net Income | -55.36M |
| EBITDA | -60.72M |
| EBIT | -62.28M |
| Earnings Per Share (EPS) | -1.91 |
Balance Sheet
The company has 837K in cash and 22.62M in debt, giving a net cash position of -21.78M.
| Cash & Cash Equivalents | 837K |
| Total Debt | 22.62M |
| Net Cash | -21.78M |
| Retained Earnings | -176.62M |
| Total Assets | 29.69M |
| Working Capital | -33.53M |
Cash Flow
In the last 12 months, operating cash flow was -14.84M and capital expenditures -2.1M, giving a free cash flow of -16.93M.
| Operating Cash Flow | -14.84M |
| Capital Expenditures | -2.1M |
| Free Cash Flow | -16.93M |
| FCF Per Share | -0.58 |
Margins
Gross margin is -1080.19%, with operating and profit margins of -10120% and -10445.47%.
| Gross Margin | -1080.19% |
| Operating Margin | -10120% |
| Pretax Margin | -12159.43% |
| Profit Margin | -10445.47% |
| EBITDA Margin | -11456.23% |
| EBIT Margin | -10120% |
| FCF Margin | -3194.91% |
Dividends & Yields
ORGS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for ORGS.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Sep 25, 2024. It was a backward split with a ratio of 1:10.
| Last Split Date | Sep 25, 2024 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | -14.89 |
| Piotroski F-Score | 2 |